Matches in SemOpenAlex for { <https://semopenalex.org/work/W3166025818> ?p ?o ?g. }
- W3166025818 endingPage "100375" @default.
- W3166025818 startingPage "100375" @default.
- W3166025818 abstract "Optimum management of patients with cancer during the COVID-19 pandemic has proved extremely challenging. Patients, clinicians and hospital authorities have had to balance the risks to patients of attending hospital, many of whom are especially vulnerable, with the risks of delaying or modifying cancer treatment. Those whose care has been significantly impacted include patients suffering from the effects of cancer on bone, where delivering the usual standard of care for bone support has often not been possible and clinicians have been forced to seek alternative options for adequate management. At a virtual meeting of the Cancer and Bone Society in July 2020, an expert group shared experiences and solutions to this challenge, following which a questionnaire was sent internationally to the symposium’s participants, to explore the issues faced and solutions offered. 70 respondents, from 9 countries (majority USA, 39%, followed by UK, 19%) included 50 clinicians, spread across a diverse range of specialties (but with a high proportion, 64%, of medical oncologists) and 20 who classified themselves as non-clinical (solely lab-based). Spread of clinician specialty across tumour types was breast (65%), prostate (27%), followed by renal, myeloma and melanoma. Analysis showed that management of metastatic bone disease in all solid tumour types and myeloma, adjuvant bisphosphonate breast cancer therapy and cancer treatment induced bone loss, was substantially impacted. Respondents reported delays to routine CT scans (58%), standard bone scans (48%) and MRI scans (46%), though emergency scans were less affected. Delays in palliative radiotherapy for bone pain were reported by 31% of respondents with treatments often involving only a single dose without fractionation. Delays to, or cancellation of, prophylactic surgery for bone pain were reported by 35% of respondents. Access to treatments with intravenous bisphosphonates and subcutaneous denosumab was a major problem, mitigated by provision of drug administration at home or in a local clinic, reduced frequency of administration or switching to oral bisphosphonates taken at home. The questionnaire also revealed damaging delays or complete stopping of both clinical and laboratory research. In addition to an analysis of the questionnaire, this paper presents a rationale and recommendations for adaptation of the normal guidelines for protection of bone health during the pandemic." @default.
- W3166025818 created "2021-06-22" @default.
- W3166025818 creator A5000897402 @default.
- W3166025818 creator A5013118794 @default.
- W3166025818 creator A5029419677 @default.
- W3166025818 creator A5031095652 @default.
- W3166025818 creator A5033241583 @default.
- W3166025818 creator A5034047848 @default.
- W3166025818 creator A5035798552 @default.
- W3166025818 creator A5046230249 @default.
- W3166025818 creator A5047832949 @default.
- W3166025818 creator A5056951639 @default.
- W3166025818 creator A5067966389 @default.
- W3166025818 creator A5070338465 @default.
- W3166025818 creator A5080382361 @default.
- W3166025818 creator A5081618476 @default.
- W3166025818 creator A5084650683 @default.
- W3166025818 creator A5088707445 @default.
- W3166025818 date "2021-08-01" @default.
- W3166025818 modified "2023-10-13" @default.
- W3166025818 title "Management of bone metastasis and cancer treatment-induced bone loss during the COVID-19 pandemic: An international perspective and recommendations" @default.
- W3166025818 cites W1999311566 @default.
- W3166025818 cites W2061202924 @default.
- W3166025818 cites W2123367264 @default.
- W3166025818 cites W2172170054 @default.
- W3166025818 cites W2529307941 @default.
- W3166025818 cites W2558977844 @default.
- W3166025818 cites W2562306819 @default.
- W3166025818 cites W2581286732 @default.
- W3166025818 cites W2594420699 @default.
- W3166025818 cites W2596883961 @default.
- W3166025818 cites W2763711876 @default.
- W3166025818 cites W2765774285 @default.
- W3166025818 cites W2766547212 @default.
- W3166025818 cites W2791058703 @default.
- W3166025818 cites W2901920153 @default.
- W3166025818 cites W2945857099 @default.
- W3166025818 cites W2973754763 @default.
- W3166025818 cites W2998985226 @default.
- W3166025818 cites W3003573098 @default.
- W3166025818 cites W3005725713 @default.
- W3166025818 cites W3035007021 @default.
- W3166025818 cites W3046710863 @default.
- W3166025818 cites W3048934302 @default.
- W3166025818 cites W3091531967 @default.
- W3166025818 cites W3128465358 @default.
- W3166025818 cites W4211076416 @default.
- W3166025818 doi "https://doi.org/10.1016/j.jbo.2021.100375" @default.
- W3166025818 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8192265" @default.
- W3166025818 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34131559" @default.
- W3166025818 hasPublicationYear "2021" @default.
- W3166025818 type Work @default.
- W3166025818 sameAs 3166025818 @default.
- W3166025818 citedByCount "7" @default.
- W3166025818 countsByYear W31660258182021 @default.
- W3166025818 countsByYear W31660258182022 @default.
- W3166025818 countsByYear W31660258182023 @default.
- W3166025818 crossrefType "journal-article" @default.
- W3166025818 hasAuthorship W3166025818A5000897402 @default.
- W3166025818 hasAuthorship W3166025818A5013118794 @default.
- W3166025818 hasAuthorship W3166025818A5029419677 @default.
- W3166025818 hasAuthorship W3166025818A5031095652 @default.
- W3166025818 hasAuthorship W3166025818A5033241583 @default.
- W3166025818 hasAuthorship W3166025818A5034047848 @default.
- W3166025818 hasAuthorship W3166025818A5035798552 @default.
- W3166025818 hasAuthorship W3166025818A5046230249 @default.
- W3166025818 hasAuthorship W3166025818A5047832949 @default.
- W3166025818 hasAuthorship W3166025818A5056951639 @default.
- W3166025818 hasAuthorship W3166025818A5067966389 @default.
- W3166025818 hasAuthorship W3166025818A5070338465 @default.
- W3166025818 hasAuthorship W3166025818A5080382361 @default.
- W3166025818 hasAuthorship W3166025818A5081618476 @default.
- W3166025818 hasAuthorship W3166025818A5084650683 @default.
- W3166025818 hasAuthorship W3166025818A5088707445 @default.
- W3166025818 hasBestOaLocation W31660258181 @default.
- W3166025818 hasConcept C121608353 @default.
- W3166025818 hasConcept C126322002 @default.
- W3166025818 hasConcept C159110408 @default.
- W3166025818 hasConcept C177713679 @default.
- W3166025818 hasConcept C20387591 @default.
- W3166025818 hasConcept C2776286101 @default.
- W3166025818 hasConcept C2776364478 @default.
- W3166025818 hasConcept C2776541429 @default.
- W3166025818 hasConcept C2777783956 @default.
- W3166025818 hasConcept C2779134260 @default.
- W3166025818 hasConcept C2994186709 @default.
- W3166025818 hasConcept C3008058167 @default.
- W3166025818 hasConcept C509974204 @default.
- W3166025818 hasConcept C512399662 @default.
- W3166025818 hasConcept C524204448 @default.
- W3166025818 hasConcept C530470458 @default.
- W3166025818 hasConcept C71924100 @default.
- W3166025818 hasConcept C89623803 @default.
- W3166025818 hasConceptScore W3166025818C121608353 @default.
- W3166025818 hasConceptScore W3166025818C126322002 @default.
- W3166025818 hasConceptScore W3166025818C159110408 @default.
- W3166025818 hasConceptScore W3166025818C177713679 @default.
- W3166025818 hasConceptScore W3166025818C20387591 @default.